trial

Efficacy of Repyflec Cognitive Remediation Group Training in Schizophrenia

NCTId NCT01279070
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 62 (actual)
Sponsored by Fundació Sant Joan de Déu
Primary completion 2009-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
62 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2006-09
Primary completion
2009-01
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Repyflec cognitive remediation training

Sponsors

Fundació Sant Joan de DéuLead Sponsor

Investigators

1
Aida Farreny, PhD Psycho.Principal Investigator

Sites

1 total
Sant Boi de Llobregat, Spain

Facts & assertions

4 sourced
Enrollment
62
Phase
PHASE4
Primary Completion Date
2009-01
Status
COMPLETED
relationships
The graph out of here
drug
Repyflec cognitive remediation training
drug
lead_sponsor
Fundació Sant Joan de Déu
company
indication
Indication for Modification of Patient Cognitive Status
indication
Schizophrenia
indication
Social Adjustment
indication
investigator
Aida Farreny, PhD Psycho.
person